Investment
Features
FeesSafety
Academy
More
Pluang+

Compare uniQure N.V. Ordinary Shares (QURE) vs STMicroelectronics NV (STM) Price & Performance

uniQure N.V. Ordinary SharesTrade
STMicroelectronics NVTrade

Price performance (Past 24H)

Key statistics

uniQure N.V. Ordinary Shares vs STMicroelectronics NV — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while STMicroelectronics NV trades at $44.75 (market cap $43.80B). The key difference: STMicroelectronics NV is far larger — about 29.6× uniQure N.V. Ordinary Shares's market cap, and STMicroelectronics NV pays a 0.73% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and STMicroelectronics NV for 65 Days on average.

QURESTM
Market Cap
$1.48B$43.80B
Volume
2,488,7807,353,071
Sector
HealthTechnology
52-Week High
$70.59$79.91
52-Week Low
$9.03$21.20
Typical Hold Time
0 Days65 Days
Enterprise Value
$728.62M$41.32B
Dividend Yield
—0.73%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

uniQure N.V. Ordinary Shares

No Aura AI signal available yet.

STMicroelectronics NV

STM is trading at $46.9, down 7.09% in the last session, with a bearish technical signal. The company shows mixed fundamentals with a high P/E ratio of 94.59 but negative net income margin of -0.39%. Recent Q2 2026 earnings beat expectations with EPS of $0.31 versus $0.26 expected, while Q1 and Q4 2025 missed. Strong cash flow of $555M in 2025 and improving 2026 projections provide some optimism amid current weakness.

The outlook remains cautious with analyst consensus price target of $77.31 suggesting 65% upside potential. Key opportunities include AI data-center revenue projected to exceed $2B in 2027 and automotive sensor innovations. Risks include declining revenue trends from $17.3B in 2023 to $11.8B in 2025 and negative profitability metrics requiring careful monitoring.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QURE
100% Buy0% Sell
Avg holding period · 0 Days
STM
2% Buy98% Sell
Avg holding period · 65 Days

Top news

Latest headlines on both assets

About uniQure N.V. Ordinary Shares

uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.

Read more on QURE →

About STMicroelectronics NV

A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.

Read more on STM →